464 filings
Page 17 of 24
6-K
f62pn6pyp 3qivxegl90
7 Jan 19
Chi-Med to Present at the 37th Annual JP Morgan Healthcare Conference
6:16am
6-K
f40mu7xz4
31 Dec 18
Current report (foreign)
6:13am
6-K
1ulo8a xw27151g
20 Dec 18
Chi-Med Announces Amendment to the 2013 License & Collaboration Agreement on Fruquintinib with Eli Lilly and Company
6:19am
6-K
nhtm6qq31jjmm 51
14 Dec 18
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i
6:19am
6-K
8cpy3 nxwk08
30 Nov 18
Current report (foreign)
6:07am
6-K
ideyhldyq 5lj3b9
29 Nov 18
Current report (foreign)
6:37am
6-K
ugpmfym1oybxd705
29 Nov 18
Current report (foreign)
6:08am
6-K
1azjm dytz
26 Nov 18
Current report (foreign)
6:33am
6-K
c4h5z
16 Nov 18
Chi-Med Announces Phase III FALUCA Trial Results for Fruquintinib in Third-Line, Advanced Non-Small Cell Lung Cancer in China
6:51am
6-K
mv9 gr0978t3w24f
31 Oct 18
Current report (foreign)
6:10am
6-K
eqjw4 84o
22 Oct 18
Current report (foreign)
6:17am
6-K
85cp kylz5f
18 Oct 18
Current report (foreign)
6:36am
6-K
kh1os2 hqmtey3
5 Oct 18
Appointment of HSBC Bank plc as Joint Corporate Broker in London
6:41am
6-K
u36u7mmu ktwb
5 Sep 18
Chi-Med Announces the Approval of Fruquintinib Capsules for Previously Treated Colorectal Cancer in China
12:00am
6-K
yuwpefz wmggj6hgz5u
31 Aug 18
Current report (foreign)
12:00am
6-K
c7qpt7wvh ystpl11r
7 Aug 18
Current report (foreign)
6:24am
6-K
tsfi2cc a6yx37y
27 Jul 18
Current report (foreign)
6:25am
6-K
8cb j2h7eo
23 Jul 18
Current report (foreign)
6:38am
6-K
80p0sggtp
29 Jun 18
Chi-Med to Announce 2018 Half-Year Financial Results
6:36am
6-K
p1k0njqc07738 5urc9c
7 Jun 18
Current report (foreign)
6:48am